Study 201312: A Multi-Centre, Open-Label, Study of Mepolizumab in a Subset of Subjects With a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial

Trial Profile

Study 201312: A Multi-Centre, Open-Label, Study of Mepolizumab in a Subset of Subjects With a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 20 Aug 2017

At a glance

  • Drugs Mepolizumab (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms Asthma
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 05 Aug 2017 This trial has been completed in Germany.
    • 21 Apr 2017 Planned primary completion date changed from 1 Jun 2017 to 29 Sep 2017.
    • 02 Apr 2017 Trial has been completed in Spain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top